(Q40345316)

19 September 2017

In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model (English)

1 reference

19 September 2017

0 references

Streptococcus pneumoniae

1 reference

11

Shigeru Kohno

1 reference

19 September 2017

4

Yoshitsugu Miyazaki

1 reference

19 September 2017

2

Katsunori Yanagihara

1 reference

19 September 2017

5

Kazuhiro Tsukamoto

1 reference

19 September 2017

6

Yoichi Hirakata

1 reference

19 September 2017

7

Kazunori Tomono

1 reference

19 September 2017

9

Takayoshi Tashiro

1 reference

19 September 2017

8

Jun-ichi Kadota

1 reference

19 September 2017

Yoshiko Otsu

1

1 reference

19 September 2017

Yuichi Fukuda

series ordinal

3

1 reference

19 September 2017

Ikuo Murata

series ordinal

10

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Antimicrobial Agents and Chemotherapy

19 September 2017

1 reference

19 September 2017

47

1 reference

19 September 2017

12

1 reference

19 September 2017

3699-3703

1 reference

In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates

19 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Antipneumococcal activities of gemifloxacin compared to those of nine other agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

The impact of antimicrobial resistance: changing epidemiology of community-acquired respiratory-tract infections.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296211

[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)]

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14638468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA/J mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14638468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14638468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.47.12.3699-3703.2003

1 reference

19 September 2017

1 reference

19 September 2017

PubMed publication ID

14638468

1 reference